Literature DB >> 19943761

Prioritization of cancer antigens: keeping the target in sight.

Joshua M Lang1, Adin-Cristian Andrei, Douglas G McNeel.   

Abstract

Entities:  

Year:  2009        PMID： 19943761     DOI： 10.1586/erv.09.134

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN： 1476-0584            Impact factor:   5.217


× No keyword cloud information.
  9 in total

1.  Presentation of underglycosylated mucin 1 in pancreatic adenocarcinoma (PDAC) at early stages.

Authors:  Su-Tang Lo; Pamela Pantazopouos; Zdravka Medarova; Anna Moore
Journal:  Am J Cancer Res       Date:  2016-09-01       Impact factor: 6.166

Review 2.  NGcGM3 ganglioside: a privileged target for cancer vaccines.

Authors:  Luis E Fernandez; Mariano R Gabri; Marcelo D Guthmann; Roberto E Gomez; Silvia Gold; Leonardo Fainboim; Daniel E Gomez; Daniel F Alonso
Journal:  Clin Dev Immunol       Date:  2010-10-27

3.  Cancer antigen prioritization: a road map to work in defining vaccines against specific targets. A point of view.

Authors:  Daniel E Gomez; Ana María Vázquez; Daniel F Alonso
Journal:  Front Oncol       Date:  2012-06-28       Impact factor: 6.244

Review 4.  Design of universal cancer vaccines using natural tumor vessel-specific antigens (SANTAVAC).

Authors:  Petr G Lokhov; Elena E Balashova
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

5.  Tumour antigen expression in hepatocellular carcinoma in a low-endemic western area.

Authors:  K Sideras; S J Bots; K Biermann; D Sprengers; W G Polak; J N M IJzermans; R A de Man; Q Pan; S Sleijfer; M J Bruno; J Kwekkeboom
Journal:  Br J Cancer       Date:  2015-06-09       Impact factor: 7.640

6.  Allogeneic Antigen Composition for Preparing Universal Cancer Vaccines.

Authors:  Petr G Lokhov; Elena E Balashova
Journal:  J Immunol Res       Date:  2016-10-03       Impact factor: 4.818

7.  SANTAVAC ™: A Novel Universal Antigen Composition for Developing Cancer Vaccines.

Authors:  Petr G Lokhov; Elena E Balashova
Journal:  Recent Pat Biotechnol       Date:  2017

8.  Tumor-induced endothelial cell surface heterogeneity directly affects endothelial cell escape from a cell-mediated immune response in vitro.

Authors:  Petr G Lokhov; Elena E Balashova
Journal:  Hum Vaccin Immunother       Date:  2013-01       Impact factor: 3.452

9.  Streamlined selection of cancer antigens for vaccine development through integrative multi-omics and high-content cell imaging.

Authors:  Ki-Cheol Han; Daechan Park; Shinyeong Ju; Young Eun Lee; Sun-Hee Heo; Young-Ae Kim; Ji Eun Lee; Yuna Lee; Kyong Hwa Park; Se-Ho Park; Hee Jin Lee; Cheolju Lee; Mihue Jang
Journal:  Sci Rep       Date:  2020-04-03       Impact factor: 4.379
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.